Another clinical trial for treating hearing loss is coming!
Frequency Therapeutics released a press release Feb 21 describing “…a breakthrough small-molecule approach to regenerate inner ear sensory hair cells. Frequency is advancing the approach to develop a potentially restorative treatment for chronic noise-induced hearing loss.”
“Frequency’s development of a disease modifying therapeutic that can be administered with a simple injection could have a profound effect on chronic noise-induced hearing loss, our lead indication, and we are rapidly advancing this program into human clinical trials within the next 18 months,” added Chris Loose, Ph.D., Co-founder and CSO of Frequency Therapeutics.
Source: Press Releases - News & Events - Frequency Therapeutics